. SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: A Mendelian randomization study. J Alzheimers Dis. 2025 Jan 21;:13872877241309674. Epub 2025 Jan 21 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.